Vancouver Coastal Health Research Institute (VCHRI) and Vaccine Evaluation Center research coordinator Jessica Bow has accomplished something challenging for any adult – she’s earned the trust of teenagers. Bow is the B.C.

Vancouver Coastal Health Research Institute scientist Dr. Judy Illes and Dr. Jordan Tesluk, a post-doctoral fellow at the National Core for Neuroethics, see an unfortunate gap in research about environmental neuroethics, the study of how environmental changes are linked to changes in the brain and mental health and the ethics that will guide response to outcomes. Contributing to a recently published commentary article in Environmental Health, Dr. Illes and Dr.

New tools developed at the Vancouver Prostate Centre (VPC) are substantially advancing the possibility of offering precise, personalized therapies to effectively treat treatment-resistant prostate cancer, also known as metastatic castration-resistant prostate cancer (mCRPC).

Proud Mount Pleasant resident Mavreen David has felt a greater appreciation for life over the past seven years – she’s been experiencing remission from the intense pain and discomfort of active Crohn’s disease. The 38-year-old local photographer has suffered from the chronic inflammatory bowel disease for 26 years, complicated by the arthritis and depression that the condition has caused. She has undergone multiple surgeries and a gamut of treatments to make life more bearable. Despite her challenges, she feels her story is one that may give patients hope.

Vancouver Coastal Health Research Institute (VCHRI) plays a role in improving patient care in B.C. and around the world with the annual VCHRI Innovation and Translational Research Awards. The Awards are intended to help put knowledge into practice. This year, we are again proud to support innovative research that will implement research outcomes and turn discoveries into opportunities for better health and improved therapies.

Congratulations to the 2016 Innovation and Translational Research Awards recipients:

Lung cancer continues to be the most common cause of cancer death in Canada and around the world. Each year, it kills 20,000 Canadians. That’s more than breast, prostate, cervical, and colorectal cancer combined. Although the prospect of surviving clinically diagnosed lung cancer is often bleak, a tool that calculates a person’s risk of developing lung cancer offers new hope by allowing for potentially life-saving early detection of the disease.

The health benefits gained from a good night’s sleep now include a reduced risk of injury on the job. A recently published study in Thorax comparing individuals with diagnosed sleep apnea and a control group who tested negative for the sleep disorder showed that individuals with untreated sleep apnea were twice as likely to get hurt at work.